We Are a Research-Driven VC Fund with a Focus on Early-Stage Blockchain Startups
EUR Ticket Size
Molecule aims to disrupt the pharmaceutical drug discovery and development industry. Their outstanding team is building a trust-less open platform for the efficient management of pharmaceutical intellectual property (IP) between researchers and investors.
by Dr. Georg (Juri) Stricker, Nikolai Lambsdorff